Loading…
Prasol Chemicals (PRASOLCHEM)₹773.00−1.74%Specialty Chemicals
In the Jun 2026 quarter (standalone), Prasol Chemicals reported sales of ₹433 Cr, up 35.6% from Jun 2025, and net profit of ₹61.10 Cr, up 153.8% year on year. For the year to Mar 2026, sales were ₹1,231 Cr and net profit ₹83.26 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Jun 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales | 319 | 334 | 433 |
| Expenses | 280 | 304 | 344 |
| Operating Profit | 40.84 | 31.88 | 89.75 |
| OPM % | 13.1% | 10.0% | 21.0% |
| Other Income | 1.01 | 2.01 | 2.01 |
| Interest | 2.99 | 1.99 | 1.99 |
| Depreciation | 5.99 | 5.99 | 6.99 |
| Profit before tax | 32.99 | 26.97 | 83.95 |
| Tax % | 26.0% | 24.9% | 26.9% |
| Net Profit | 24.07 | 20.06 | 61.10 |
| EPS (Rs) | 4.19 | 3.41 | 10.50 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 591 | 895 | 928 | 875 | 1,011 | 1,231 |
| Expenses | 544 | 765 | 845 | 817 | 927 | 1,094 |
| Operating Profit | 48.83 | 133 | 86.63 | 61.80 | 87.64 | 139 |
| OPM % | 8.0% | 15.0% | 9.0% | 7.0% | 9.0% | 11.0% |
| Other Income | 9.01 | 7.01 | 2.01 | 4.01 | 3.01 | 4.01 |
| Interest | 11.96 | 11.96 | 11.95 | 10.95 | 7.96 | 7.97 |
| Depreciation | 12.98 | 16.99 | 18.99 | 20.98 | 22.99 | 24.97 |
| Profit before tax | 33.96 | 111 | 57.95 | 33.99 | 59.01 | 112 |
| Tax % | 26.0% | 25.9% | 16.9% | 46.0% | 26.9% | 25.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | −3.99 | 0.00 | −0.99 |
| Net Profit | 25.04 | 83.24 | 49.12 | 18.04 | 44.10 | 83.26 |
| EPS (Rs) | 86.29 | 14.19 | 8.36 | 3.12 | 7.49 | 14.29 |
| Dividend payout % | 2.0% | 0.0% | 0.0% | 10.1% | 4.0% | 8.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 3.01 | 12.02 | 12.01 | 12.02 | 12.01 | 12.02 |
| Reserves | 178 | 252 | 299 | 315 | 357 | 439 |
| Borrowings | 162 | 162 | 186 | 82.85 | 102 | 111 |
| Other Liabilities | 207 | 253 | 193 | 217 | 254 | 279 |
| Total Liabilities | 551 | 678 | 689 | 626 | 723 | 839 |
| Fixed Assets | 268 | 293 | 292 | 326 | 326 | 314 |
| CWIP | 19.96 | 24.95 | 59.89 | 21.96 | 20.94 | 46.89 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 263 | 360 | 338 | 278 | 376 | 478 |
| Inventories | 81.27 | 136 | 132 | 100 | 152 | 153 |
| Trade receivables | 146 | 174 | 168 | 160 | 197 | 279 |
| Cash & equivalents | 7.03 | 34.13 | 21.10 | 10.04 | 17.07 | 24.08 |
| Total Assets | 551 | 678 | 689 | 626 | 723 | 839 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 20.03 | 81.10 | 29.04 | 116 | 22.05 | 49.09 |
| Cash from investing activity | −40.87 | −41.89 | −53.84 | −11.96 | −25.92 | −41.85 |
| Cash from financing activity | 13.96 | −11.96 | 10.97 | −115 | 9.96 | 0.00 |
| Net cash flow | −7.02 | 28.10 | −13.04 | −11.04 | 7.02 | 7.02 |
| Capex | 47.20 | 48.14 | 52.92 | 19.15 | 22.60 | 39.02 |
| Free cash flow | −26.89 | 32.90 | −22.93 | 96.58 | 0.00 | 10.97 |
| CFO / OP % | 52.0% | 79.0% | 47.0% | 194.0% | 43.0% | 56.9% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 91 | 72 | 67 | 68 | 72 | 84 |
| Inventory days | 68 | 85 | 74 | 58 | 79 | 67 |
| Days payable | 143 | 133 | 91 | 99 | 102 | 91 |
| Cash conversion cycle | 16 | 23 | 50 | 26 | 49 | 59 |
| Working capital days | −24 | −6 | 6 | 15 | 29 | 43 |
| ROCE % | — | 32.1% | 15.0% | 11.1% | 15.0% | 24.1% |
For the Jun 2026 quarter, Prasol Chemicals reported sales of ₹433 Cr, up 35.6% year on year and net profit of ₹61.10 Cr, up 153.8% year on year. The operating margin was 21.0%.
Prasol Chemicals' sales for the year to Mar 2026 were ₹1,231 Cr.
Net profit for the year to Mar 2026 was ₹83.26 Cr. Earnings per share over the same trailing period were ₹14.29.
Prasol Chemicals reported borrowings of ₹111 Cr at Mar 2026, against cash and equivalents of ₹24.08 Cr.
Cash from operations was ₹49.09 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹10.97 Cr.